Your browser doesn't support javascript.
loading
Response to the letter to editor: Neurocognitive deficits attributed to androgen deprivation therapy in patients with prostate cancer should be reconsidered.
Ihrig, Andreas; Pernt, Pascal Marino; Zschäbitz, Stefanie; Huber, Johannes; Friederich, Hans-Christoph; Bugaj, Till J; Maatouk, Imad.
Afiliação
  • Ihrig A; Division of Psycho-Oncology, Department of General Internal Medicine and Psychosomatic, University of Heidelberg, University Hospital Heidelberg, INF 410, 69120, Heidelberg, Germany. andreas.ihrig@med.uni-heidelberg.de.
  • Pernt PM; Division of Psycho-Oncology, Department of General Internal Medicine and Psychosomatic, University of Heidelberg, University Hospital Heidelberg, INF 410, 69120, Heidelberg, Germany.
  • Zschäbitz S; Department of Medical Oncology, National Centre for Tumour Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
  • Huber J; Department of Urology, Philipps-University Marburg, Marburg, Germany.
  • Friederich HC; Division of Psycho-Oncology, Department of General Internal Medicine and Psychosomatic, University of Heidelberg, University Hospital Heidelberg, INF 410, 69120, Heidelberg, Germany.
  • Bugaj TJ; Division of Psycho-Oncology, Department of General Internal Medicine and Psychosomatic, University of Heidelberg, University Hospital Heidelberg, INF 410, 69120, Heidelberg, Germany.
  • Maatouk I; Division of Psycho-Oncology, Department of General Internal Medicine and Psychosomatic, University of Heidelberg, University Hospital Heidelberg, INF 410, 69120, Heidelberg, Germany.
Int Urol Nephrol ; 56(1): 145, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37698710

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Idioma: En Ano de publicação: 2024 Tipo de documento: Article